Fig. 7From: Baricitinib improves pulmonary fibrosis in mice with rheumatoid arthritis-associated interstitial lung disease by inhibiting the Jak2/Stat3 signaling pathwayHLF scratch assay. control, control group; TGFβ1, model group; TGFβ1 + baricitinib, intervention group. HLFs cocultured with TGFβ1 (10 ng/ml) and baricitinib (2000 nmol/ml) were subjected to a wound healing assay. Wound closure was recorded at 0, 12, and 24 h after injuryBack to article page